Stem cells in amyotrophic lateral sclerosis: state of the art

Bibliography

• Kanazawa I. How do neurons die in neurodegenerative diseases? Trends Mol Med 2001;7(8):339-44
   PubMed Web of Science ®Google Scholar
• Bradley WG. Updates on amyotrophic lateral sclerosis: improving patient care. Ann Neurol 2009;65(1):S1-2
   PubMed Web of Science ®Google Scholar
• Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 2009;65(l):S3-9
   PubMed Web of Science ®Google Scholar
• Brooks BR. Managing amyotrophic lateral sclerosis: slowing disease progression and improving patient quality of life. Ann Neurol 2009;65(1):S17-23
   PubMed Web of Science ®Google Scholar
• Lee ST, Chu K, Jung KH, et al. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 2008;131(Pt 3):616-29
   PubMed Web of Science ®Google Scholar
• Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008;8:726-36
   PubMed Web of Science ®Google Scholar
• Ben-Hur T. Immunomodulation by neural stem cells. J Neurol Sci 2008;265:102-4
   PubMed Web of Science ®Google Scholar
• Knoepfler PS. Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 2009;27:1050-6
   PubMed Web of Science ®Google Scholar
• Thonhoff JR, Jordan PM, Karam JR, et al. Identification of early disease progression in an ALS rat model. Neurosci Lett 2007;415(3):264-8
   PubMed Web of Science ®Google Scholar
• De Carvalho M, Costa J, Swash M. Clinical trials in ALS: a review of the role of clinical and neurophysiological measurements. Amyotroph Lateral Scler Other Motor Neuron Disord 2005;6(4):202-12
   PubMed Web of Science ®Google Scholar
• Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-7
   PubMed Web of Science ®Google Scholar
• Brazelton TR, Rossi FMV, Keshet GI, et al. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000;290:1775-9
   PubMed Web of Science ®Google Scholar
• Vallières L, Sawchenko PE. Bone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity. J Neurosci 2003;23:5197-207
   PubMed Web of Science ®Google Scholar
• Castro RF, Jackson KA, Goodell MA, et al. Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science 2002;297:1299
   PubMed Web of Science ®Google Scholar
• Fuchs E, Segre JA. Stem cells: a new lease on life. Cell 2000;100:143-55
   PubMed Web of Science ®Google Scholar
• Choumerianou DM, Dimitriou H, Kalmanti M. Stem cells: promises versus limitations. Tissue Eng Part B Rev 2008;14:53-60
   PubMed Web of Science ®Google Scholar
• Aejaz HM, Aleem AK, Parveen N, et al. Stem cell therapy-present status. Transplant Proc 2007;39:694-9
   PubMed Web of Science ®Google Scholar
• Henningson CT Jr, Stanislaus MA, Gewirtz AM, et al. Embryonic and adult stem cells therapy. J Allergy Clin Immunol 2003;111:S745-53
   PubMedGoogle Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-76
   PubMed Web of Science ®Google Scholar
• Chandran S. What are the prospects of stem cell therapy for neurology? BMJ 2008;337:a1934
   PubMedGoogle Scholar
• Li XJ, Du ZW, Zarnowska ED, et al. Specification of motoneurons from human embryonic stem cells. Nat Biotechnol 2005;23:215-21
   PubMed Web of Science ®Google Scholar
• Di Giorgio FP, Carrasco MA, Siao MC, et al. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 2007;10:608-14
   PubMed Web of Science ®Google Scholar
• Karumbayaram S, Kelly TK, Paucar AA, et al. Human embryonic stem cell-derived motor neurons expressing SOD1 mutants exhibit typical signs of motor neuron degeneration linked to ALS. Dis Model Mech 2009;2(3-4):189-95
   PubMed Web of Science ®Google Scholar
• Di Giorgio FP, Boulting GL, Bobrowicz S, Eggan KC. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 2008;3(6):637-48
   PubMed Web of Science ®Google Scholar
• Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 2007;1:39-49
   PubMed Web of Science ®Google Scholar
• Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can generate motor neurons. Science 2008;321:1218-21
   PubMed Web of Science ®Google Scholar
• Nishikawa S, Goldstein RA, Nierras CR. The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol 2008;9(9):725-29
   PubMed Web of Science ®Google Scholar
• Crigler L, Robey RC, Asawachaicharn A, et al. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 2006;198:54-64
   PubMed Web of Science ®Google Scholar
• Vercelli A, Mereuta OM, Garbossa D, et al. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2008;31(3):395-05
   PubMed Web of Science ®Google Scholar
• Suzuki M, Svendsen CN. Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis. Trends Neurosci 2008;31(4):192-8
   PubMed Web of Science ®Google Scholar
• Gordon D, Scolding NJ. Human mesenchymal stem cell culture for neural transplantation. Methods Mol Biol 2009;549:103-18
   PubMedGoogle Scholar
• Aiba K, Sharov A, Carter M, et al. Mouse embryonic stem cells and adult neural stem/progenitor cells defining a developmental path to neural fate by global expression profiling of mouse embryonic stem cells and adult neural stem/progenitor cells. Stem Cells 2006;24;889-95
   PubMed Web of Science ®Google Scholar
• Lladó J, Haenggeli C, Maragakis NJ, et al. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol Cell Neurosci 2004;27(3):322-31
   PubMed Web of Science ®Google Scholar
• Lepore AC, Rauck B, Dejea C, et al. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci 2008;11(11):1294-01
   PubMed Web of Science ®Google Scholar
• Martino G, Pluchino S. The therapeutic potential of neural stem cells. Nat Rev Neurosci 2006;7(5):395-06
   PubMed Web of Science ®Google Scholar
• Tsyb AF, Yuzhakov VV, Roshal' LM, et al. Morphofunctional study of the therapeutic efficacy of human mesenchymal and neural stem cells in rats with diffuse brain injury. Bull Exp Biol Med 2009;147(1):132-46
   PubMed Web of Science ®Google Scholar
• Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 1992;140(3):691-07
   PubMed Web of Science ®Google Scholar
• Ende N, Weinstein F, Chen R, Ende M. Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). Life Sci 2000;67(1):53-9
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Willing AE, Zigova T, et al. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. Hematother Stem Cell Res 2003;12(3):255-70
   PubMedGoogle Scholar
• Mareschi K, Novara M, Rustichelli D, et al. Neural differentiation of human mesenchymal stem cells: evidence for expression of neural markers and eag K+ channel types. Exp Hematol 2006;34:1563-72
   PubMed Web of Science ®Google Scholar
• Ferrero I, Mazzini L, Rustichelli D, et al. Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients. Cell Transplant 2008;17(3):255-66
   PubMed Web of Science ®Google Scholar
• Yan J, Xu L, Welsh A, et al. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Stem Cells 2006;24:1976-85
   PubMed Web of Science ®Google Scholar
• Xu L, Ryugo DK, Pongstaporn T, et al. Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: differentiation and structural integration into the segmental motor circuitry. J Comp Neurol 2009;514:297-9
   PubMed Web of Science ®Google Scholar
• Corti S, Locatelli F, Papadimitriou D, et al. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model. Brain 2007;130(Pt 5):1289-305
   PubMed Web of Science ®Google Scholar
• Hedlund E, Hefferan MP, Marsala M, Isacson O. Cell therapy and stem cells in animal models of motor neuron disorders. Eur J Neurosci 2007;26:1721-37
   PubMed Web of Science ®Google Scholar
• De Hemptinne I, Boucherie C, Pochet R, et al. Unilateral induction of progenitors in the spinal cord of hSOD1G93A transgenic rats correlates with an asymmetrical hind limb paralysis. Neurosci Lett 2006;401:25-9
   PubMed Web of Science ®Google Scholar
• Liu Z, Martin LJ. The adult neural stem and progenitor cell niche is altered in amyotrophic lateral sclerosis mouse brain. J Comp Neurol 2006;497:468-88
   PubMed Web of Science ®Google Scholar
• Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 2005;19:1129-55
   PubMed Web of Science ®Google Scholar
• Deshpande DM, Kim YS, Martinez T, et al. Recovery from paralysis in adult rats using embryonic stem cells. Ann Neurol 2006;60:32-44
   PubMed Web of Science ®Google Scholar
• Vogel G. Cell biology. Ready or not? Human ES cells head toward the clinic. Science 2005;308:1534-38
   PubMed Web of Science ®Google Scholar
• Galli R, Gritti A, Bonfanti L, Vescovi L. Neural stem cells: an overview. Circ Res 2003;92:598-08
   PubMed Web of Science ®Google Scholar
• Emgård M, Holmberg L, Samuelsson EB, et al. Human neural precursor cells continue to proliferate and exhibit low cell death after transplantation to the injured rat spinal cord. Brain Res 2009;30(1278):15-26
   Google Scholar
• Capowski EE, Schneider BL, Ebert AD, et al. Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy. J Neurosci Methods 2007;30:163(2):338-49
   Google Scholar
• Klein SM, Behrstock S, McHugh J, et al. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther 2005;16(4):509-21
   PubMed Web of Science ®Google Scholar
• Suzuki M, McHugh J, Tork C, et al. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS ONE 2007;2(1):e689, published online 1 August 2007 doi:10.1371/journal.pone.0000689
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Willing AE, Milliken M, et al. Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis. Exp Neurol 2002;174(2):169-80
   PubMed Web of Science ®Google Scholar
• Neusch C, Bähr M, Schneider-Gold C. Glia cells in amyotrophic lateral sclerosis: new clues to understanding an old disease? Muscle Nerve 2007;35(6):712-24
   PubMed Web of Science ®Google Scholar
• Van Den Bosch L, Robberecht W. Crosstalk between astrocytes and motor neurons: what is the message? Exp Neurol 2008;211(1):1-6
   PubMed Web of Science ®Google Scholar
• Huard J, Youngento B, Goldstein B, et al. Adult olfactory epithelium contains multipotent progenitors that give rise to neurons and non-neural cells. J Comp Neurol 1998;400:469-86
   PubMed Web of Science ®Google Scholar
• Richter MW, Roskams AJ. Olfactory ensheathing cell transplantation following spinal cord injury: hype or hope? Exp Neurol 2008;209:353-67
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Sanberg PR. Feasibility of cell therapy for amyotrophic lateral sclerosis. Exp Neurol 2009;216(1):3-6
   PubMed Web of Science ®Google Scholar
• Bonilla S, Silva A, Geijo E, et al. Functional neural stem cells derived from adult bone marrow. Neuroscience 2005;133:85-95
   PubMed Web of Science ®Google Scholar
• Moraleda JM, Blanquer M, Bleda P, et al. Adult stem cell therapy: dream or reality? Transpl Immunol 2006;17:74-7
   PubMed Web of Science ®Google Scholar
• Beers DR, Henkel JS, Zhao W, et al. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc Natl Acad Sci USA 2008;105(40):1558-63
   Google Scholar
• Rice CM, Scolding NJ. Adult stem cells for the treatment of neurological disease. Methods Mol Biol 2009;549:17-32
   PubMedGoogle Scholar
• Chen Y, Shao JZ, Xiang LX, et al. Mesenchymal stem cells: a promising candidate in regenerative medicine. Int J Biochem Cell Biol 2008;40(5):815-20
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Willing AE, Saporta S, et al. Novel cell therapy approaches for brain repair. Prog Brain Res 2006;157:207-22
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-17
   PubMed Web of Science ®Google Scholar
• Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair–current views. Stem Cells 2007;25(11):2896-902
   PubMed Web of Science ®Google Scholar
• Woodbury D, Schwarz EJ, Prockop DJ, et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000;61:364-70
   PubMed Web of Science ®Google Scholar
• Deng W, Obrocka M, Fischer I, et al. In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem Biophys Res Commun 2001;282:148-52
   PubMed Web of Science ®Google Scholar
• Kohyama J, Abe H, Shimazaki T. Brain from bone: efficient metadifferentiation of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. Differentiation 2001;68:235-44
   PubMed Web of Science ®Google Scholar
• Kim BJ, Seo JH, Bubien JK, et al. Differentiation of adult bone marrow stem cells into neuroprogenitor cells in vitro. Neuroreport 2002;13:1185-8
   PubMed Web of Science ®Google Scholar
• Muñoz-Elías G, Woodbury D, Black IB. Marrow stromal cells, mitosis, and neuronal differentiation: stem cell and precursor functions. Stem Cells 2003;21:437-48
   PubMed Web of Science ®Google Scholar
• Sanchez-Ramos J, Song S, Cardozo-Pelaez F, et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 2000;164:247-56
   PubMed Web of Science ®Google Scholar
• Lu P, Blesch A, Tuszynski MH. Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact? J Neurosci Res 2004;77:174-91
   PubMed Web of Science ®Google Scholar
• Bertani N, Malatesta P, Volpi G, et al. Neurogenic potential of human mesenchymal stem cells revisited: analysis by immunostaining, time-lapse video and microarray. J Cell Sci 2005;118:3925-36
   PubMed Web of Science ®Google Scholar
• Kim J, Kang JW, Park JH, et al. Biological characterization of long-term cultured human mesenchymal stem cells. Arch Pharm Res 2009;32(1):117-26
   PubMed Web of Science ®Google Scholar
• Minguell JJ, Fierro FA, Epunan MJ, et al. Nonstimulated human uncommitted mesenchymal stem cells express cell markers of mesenchymal and neural lineages. Stem Cells Dev 2005;14:408-14
   PubMed Web of Science ®Google Scholar
• Blondheim NR, Levy YS, Ben-Zur T, et al. Human mesenchymal stem cells express neural genes, suggesting a neural predisposition. Stem Cells Dev 2006;15:141-64
   PubMed Web of Science ®Google Scholar
• Rice CM, Scolding NJ. Adult stem cells–reprogramming neurological repair? Lancet 2004;364(9429):193-9
   PubMed Web of Science ®Google Scholar
• Abdi R, Fiorina P, Adra CN, et al. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes 2008;57(7):1759-67
   PubMed Web of Science ®Google Scholar
• Uccelli A, Zappia E, Benvenuto F, et al. Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection. Expert Opin Biol Ther 2006;6:17-22
   PubMed Web of Science ®Google Scholar
• Borchelt DR. Amyotrophic lateral sclerosis–are microglia killing motor neurons? N Engl J Med 2005;55:1611-13
   Google Scholar
• Feeney SJ, McKelvie PA, Austin L, et al. Presymptomatic motor neuron loss and reactive astrocytosis in the SOD1 mouse model of amyotrophic lateral sclerosis. Muscle Nerve 2001;24:1510-9
   PubMed Web of Science ®Google Scholar
• Christou YA, Moore HD, Shaw PJ, et al. Embryonic stem cells and prospects for their use in regenerative medicine approaches to motor neuron disease. Neuropathol Appl Neurobiol 2007;33:485-98
   PubMed Web of Science ®Google Scholar
• Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98:1076-84
   PubMed Web of Science ®Google Scholar
• Hamada H, Kobune M, Nakamura K, et al. Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci 2005;96:149-56
   PubMed Web of Science ®Google Scholar
• Zwart I, Hill AJ, Al-Allaf F, et al. Umbilical cord blood mesenchymal stromal cells are neuroprotective and promote regeneration in a rat optic tract model. Exp Neurol 2009;216(2):439-48
   PubMed Web of Science ®Google Scholar
• Liu H, Honmou O, Harada K, et al. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain 2006;129:2734-45
   PubMed Web of Science ®Google Scholar
• McMahon JM, Conroy S, Lyons M, et al. Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors. Stem Cells Dev 2006;15:87-96
   PubMed Web of Science ®Google Scholar
• Suzuki M, McHugh J, Tork C, et al. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther 2008;16(12):2002-10
   PubMed Web of Science ®Google Scholar
• Bernardo ME, Zaffaroni N, Novara F, et al. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 2007;67(19):9142-49
   PubMed Web of Science ®Google Scholar
• Choumerianou DM, Dimitriou H, Perdikogianni C, et al. Study of oncogenic transformation in ex vivo expanded mesenchymal cells, from paediatric bone marrow. Cell Prolif 2008;41(6):909-22
   PubMed Web of Science ®Google Scholar
• Zhong Z, Deane R, Ali Z, et al. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci 2008;11:420-2
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Haller E, Saporta S, et al. Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Res 2007;1157:126-37
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Sanberg CD, Kuzmin-Nichols N, et al. Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS ONE 2008;3(6):e2494, published online 25 June 2008, doi:10.1371/journal.pone.0002494
   PubMed Web of Science ®Google Scholar
• Corti S, Locatelli F, Donadoni C, et al. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain 2004;127:2518-32
   PubMed Web of Science ®Google Scholar
• Corti S, Locatelli F, Papadimitriou D, et al. Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1. Hum Mol Genet 2006;15(2):167-87
   PubMed Web of Science ®Google Scholar
• Habisch HJ, Janowski M, Binder D, et al. Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects. J Neural Transm 2007;114(11):1395-06
   PubMed Web of Science ®Google Scholar
• Morita E, Watanabe Y, Ishimoto M, et al. A novel cell transplantation protocol and its application to an ALS mouse model. Exp Neurol 2008;213(2):431-38
   PubMed Web of Science ®Google Scholar
• Janson CG, Ramesh TM, During MJ, et al. Human intrathecal transplantation of peripheral blood stem cells in amyotrophic Lateral Sclerosis. J Hemat Stem Cell Res 2001;10:913-15
   PubMedGoogle Scholar
• Garbuzova-Davis S, Willing AE, Milliken M, et al. Intraspinal implantation of hNT neurons into SOD1 mice with apparent motor deficit. Amyotroph Lateral Scler Other Motor Neuron Disord 2001;2:175-80
   PubMed Web of Science ®Google Scholar
• Hemendinger R, Wang J, Malik S, et al. Sertoli cells improve survival of motor neurons in SOD1 transgenic mice, a model of amyotrophic lateral sclerosis. Exp Neurol 2005;196:235-43
   PubMed Web of Science ®Google Scholar
• Nagai M, Re DB, Nagata T, et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 2007;10:615-22
   PubMed Web of Science ®Google Scholar
• Riley J, Butler J, Baker KB, et al. Targeted spinal cord therapeutics delivery: stabilized platform and microelectrode recording guidance validation. Stereotact Funct Neurosurg 2008;86(2):67-74
   PubMed Web of Science ®Google Scholar
• Dobrowolny G, Aucello M, Rizzuto E, et al. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab 2008;8(5):425-36
   PubMed Web of Science ®Google Scholar
• Guillot S, Azzouz M, Déglon N, et al. Local GDNF expression mediated by lentiviral vector protects facial nerve motoneurons but not spinal motoneurons in SOD1G93A transgenic mice. Neurobiol Dis 2004;16:139-49
   PubMed Web of Science ®Google Scholar
• Mohajeri MH, Figlewicz DA, Bohn MC. Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Hum Gene Ther 1999;10(11):1853-66
   PubMed Web of Science ®Google Scholar
• Guidelines for the Clinical Translation of Stem Cells. Deerfield, Illinois, International Society for Stem Cell Research, 2008. Available from: http://www.isscr.org/clinical_trans/. [Last accessed 31 July 2009]
   Google Scholar
• Mazzini L, Mareschi K, Ferrero I, et al. Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci 2008;265:78-83
   PubMed Web of Science ®Google Scholar
• Cashman N, Tan LY, Krieger C, et al. Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS). Muscle Nerve 2008;37:620-25
   PubMed Web of Science ®Google Scholar
• Appel SH, Engelhardt JI, Henkel JS. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology 2008;71:1326-34
   PubMed Web of Science ®Google Scholar
• Deda H, Inci MC, Kürekçi AE, et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy 2009;11(1):18-2
   PubMed Web of Science ®Google Scholar
• Martinez HR, Gonzalez-Garza MT, Moreno-Cuevas JE, et al. Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy 2009;11(1):26-34
   PubMed Web of Science ®Google Scholar
• Xu L, Yan J, Chen D, et al. Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation 2006;82:865-75
   PubMed Web of Science ®Google Scholar
• Boucherie C, Schäfer S, Lavand'homme P, et al. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis. J Neurosci Res 2009;87(9):2034-46
   PubMed Web of Science ®Google Scholar